Striatal Medium Spiny Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Striatal medium spiny neurons (MSNs) are the principal neurons of the striatum, comprising approximately 95% of striatal neurons. They are the primary projection neurons of the basal ganglia and play critical roles in motor control, habit formation, and reward learning.
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
The striatum consists of the caudate nucleus and putamen. MSNs are distributed throughout these structures, with slight regional variations in neurochemical properties.
MSNs have a small cell body (10-20 μm diameter) with densely spiny dendrites. Their name derives from the numerous dendritic spines that receive excitatory inputs from the cortex and thalamus.
MSNs project via two distinct pathways:
MSNs are severely affected in PD due to:
MSNs are particularly vulnerable in HD:
The study of Striatal Medium Spiny Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.